These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25169523)

  • 41. Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects.
    Yang XI; Zhu Y; Ye D; Liu Y; Sun H; Ruan M; Liu W
    Mol Clin Oncol; 2016 Jul; 5(1):175-180. PubMed ID: 27330794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis.
    Yang J; Gao W; Song NH; Wang W; Zhang JX; Lu P; Hua LX; Gu M
    Asian J Androl; 2012 Sep; 14(5):726-31. PubMed ID: 22902907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Murine double minute 2 rs2279744 polymorphism and hepatocellular carcinoma risk in East Asians: a meta-analysis.
    Liu Y; Kuang S; Zheng J; Zheng J; Jin H; Chen S; Jian Z
    Tumour Biol; 2014 Feb; 35(2):961-5. PubMed ID: 24061636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
    Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
    Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis.
    Liu G; Jiang D; Shen S; Yu L
    Int J Urol; 2012 Oct; 19(10):914-20. PubMed ID: 22716509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.
    Luan L; Wang H; Zhao B; Wang F; Shi J; Xu X
    Pathol Res Pract; 2019 Sep; 215(9):152538. PubMed ID: 31326197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
    Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ
    Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.
    Ma HB; Huang T; Han F; Chen WY
    Asian Pac J Cancer Prev; 2012; 13(6):2841-6. PubMed ID: 22938470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The MDM2 promoter T309G polymorphism was associated with preeclampsia susceptibility.
    Salimi S; Mohammadpour-Gharehbagh A; Rezaei M; Sajadian M; Teimoori B; Yazdi A; Mokhtari M; Yaghmaei M
    J Assist Reprod Genet; 2017 Jul; 34(7):951-956. PubMed ID: 28508227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
    Fu Q; Zhang G; Chen H; Zheng Y; Cheng J
    Tumour Biol; 2013 Dec; 34(6):3721-9. PubMed ID: 23912932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of the
    Wang P; Wang M; Li S; Ma L; Xi S; He J
    Dis Markers; 2016; 2016():4585484. PubMed ID: 27890964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients.
    Pan X; Li Y; Feng J; Wang X; Hao B; Shi R; Zhang G
    BMC Cancer; 2013 Mar; 13():126. PubMed ID: 23506213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-23 receptor genetic polymorphisms and ulcerative colitis susceptibility: A meta-analysis.
    Liu M; Zhu W; Wang J; Zhang J; Guo X; Wang J; Song J; Dong W
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):516-25. PubMed ID: 25497273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
    Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutiérrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; VanMeurs JC; González-Sarmiento R; Pastor JC;
    PLoS One; 2013; 8(12):e82283. PubMed ID: 24349246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of
    Sivonova MK; Jurecekova J; Kaplan P; Hives M; Grendar M; Tomascova A; Dusenka R; Drobkova H; Evin D; Kliment J
    Anticancer Res; 2020 Nov; 40(11):6257-6264. PubMed ID: 33109563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IKZF1 rs4132601 polymorphism and acute lymphoblastic leukemia susceptibility: a meta-analysis.
    Li S; Ren L; Fan L; Wang G
    Leuk Lymphoma; 2015 Apr; 56(4):978-82. PubMed ID: 25012940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
    Wan Y; Wu W; Yin Z; Guan P; Zhou B
    BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.
    Zhou L; Yao F; Luan H; Wang Y; Dong X; Zhou W; Wang Q
    Breast Cancer Res Treat; 2012 Dec; 136(3):885-97. PubMed ID: 23124475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.
    Gui XH; Qiu LX; Zhang HF; Zhang DP; Zhong WZ; Li J; Xiao YL
    Eur J Cancer; 2009 Jul; 45(11):2023-6. PubMed ID: 19264476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis.
    Economopoulos KP; Sergentanis TN
    Breast Cancer Res Treat; 2010 Feb; 120(1):211-6. PubMed ID: 19590949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.